Kanwal Raghav
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Hepatocellular Carcinoma Treatment and Prognosis, Cancer Genomics and Diagnostics, Gastric Cancer Management and Outcomes, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer(2018)345 cited
- → cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes(2012)128 cited
- → Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers(2011)96 cited
- → Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up(2016)86 cited
- → Small Bowel Adenocarcinoma: Etiology, Presentation, and Molecular Alterations(2019)69 cited
- → Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients(2016)58 cited
- → Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma(2016)58 cited
- → Impact of Molecular Alterations and Targeted Therapy in Appendiceal Adenocarcinomas(2013)56 cited
- → Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer(2017)54 cited
- → Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma(2019)54 cited